These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35304166)

  • 1. Reply to: "Comment on: Bicalutamide Improves Minoxidil-Induced Hypertrichosis in Female Pattern Hair Loss: A Retrospective Review of 35 Patients".
    Moussa A; Kazmi A; Bokhari L; Sinclair RD
    J Am Acad Dermatol; 2022 Jul; 87(1):e31-e32. PubMed ID: 35304166
    [No Abstract]   [Full Text] [Related]  

  • 2. Bicalutamide improves minoxidil-induced hypertrichosis in female pattern hair loss: A retrospective review of 35 patients.
    Moussa A; Kazmi A; Bokhari L; Sinclair RD
    J Am Acad Dermatol; 2022 Aug; 87(2):488-490. PubMed ID: 34740752
    [No Abstract]   [Full Text] [Related]  

  • 3. Comment on "Bicalutamide Improves Minoxidil-Induced Hypertrichosis in Female Pattern Hair Loss: A Retrospective Review of 35 Patients".
    Trüeb RM; Luu NC; Rezende HD
    J Am Acad Dermatol; 2022 Jul; 87(1):e29-e30. PubMed ID: 35304167
    [No Abstract]   [Full Text] [Related]  

  • 4. Significant hair regrowth in a Middle Eastern woman with central centrifugal cicatricial alopecia.
    Lobon K; Pinczewski J; Bhoyrul B
    Clin Exp Dermatol; 2022 Jan; 47(1):136-138. PubMed ID: 34192377
    [No Abstract]   [Full Text] [Related]  

  • 5. Diffuse hypertrichosis during treatment with 5% topical minoxidil.
    Peluso AM; Misciali C; Vincenzi C; Tosti A
    Br J Dermatol; 1997 Jan; 136(1):118-20. PubMed ID: 9039309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three percent topical minoxidil therapy for female androgenetic alopecia.
    Hordinsky MK; Shank J
    Clin Dermatol; 1988; 6(4):213-7. PubMed ID: 3214822
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe hypertrichosis in infants due to transdermic exposure to 5% and 7% topical minoxidil.
    Rica Echevarría I; García Del Monte J; Delgado Rubio A; Arcangeli F; Lotti T
    Dermatol Ther; 2020 Nov; 33(6):e14230. PubMed ID: 32844481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Piggyback-acquired hypertrichosis.
    Farsani TT; Kane MJ; Kane KS
    Pediatr Dermatol; 2014; 31(4):520-2. PubMed ID: 24915767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A child with generalized hypertrichosis due to secondary topical minoxidil exposure.
    Maltoni G; Cedirian S; Scozzarella A; Bernardini L; Piraccini BM; Starace M
    Pediatr Dermatol; 2023; 40(4):753-754. PubMed ID: 37042338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generalized Hypertrichosis Due to Topical Minoxidil.
    Gargallo V; Gutierrez C; Vanaclocha F; Guerra-Tapia A
    Actas Dermosifiliogr; 2015 Sep; 106(7):599-600. PubMed ID: 25688008
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral bicalutamide for female pattern hair loss: A pilot study.
    Fernandez-Nieto D; Saceda-Corralo D; Rodrigues-Barata R; Hermosa-Gelbard A; Moreno-Arrones O; Jimenez-Cauhe J; Ortega-Quijano D; Vano-Galvan S
    Dermatol Ther; 2019 Nov; 32(6):e13096. PubMed ID: 31579984
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety of oral bicalutamide in female pattern hair loss: A retrospective review of 316 patients.
    Ismail FF; Meah N; Trindade de Carvalho L; Bhoyrul B; Wall D; Sinclair R
    J Am Acad Dermatol; 2020 Nov; 83(5):1478-1479. PubMed ID: 32213304
    [No Abstract]   [Full Text] [Related]  

  • 13. Systemic minoxidil for hair disorders in pediatric patients: a safety and tolerability review.
    John JM; Sinclair RD
    Int J Dermatol; 2023 Feb; 62(2):257-259. PubMed ID: 35965281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minoxidil induced hypertrichosis in children.
    Guerouaz N; Mohamed AO
    Pan Afr Med J; 2014; 18():8. PubMed ID: 25360192
    [No Abstract]   [Full Text] [Related]  

  • 15. Infantile generalized hypertrichosis caused by topical minoxidil.
    Rampon G; Henkin C; de Souza PR; Almeida HL
    An Bras Dermatol; 2016; 91(1):87-8. PubMed ID: 26982785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bicalutamide: A potential new oral antiandrogenic drug for female pattern hair loss.
    Fernandez-Nieto D; Saceda-Corralo D; Jimenez-Cauhe J; Moreno-Arrones OM; Rodrigues-Barata R; Hermosa-Gelbard A; Vano-Galvan S
    J Am Acad Dermatol; 2020 Nov; 83(5):e355-e356. PubMed ID: 32320770
    [No Abstract]   [Full Text] [Related]  

  • 17. Topical minoxidil for hair loss in women.
    Hong D; Hart LL
    DICP; 1990 Nov; 24(11):1062-3. PubMed ID: 2275230
    [No Abstract]   [Full Text] [Related]  

  • 18. Generalized hypertrichosis after treatment with topical minoxidil.
    González M; Landa N; Gardeazabal J; Calderón MJ; Bilbao I; Díaz Pérez JL
    Clin Exp Dermatol; 1994 Mar; 19(2):157-8. PubMed ID: 8050148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertrichosis in females applying minoxidil topical solution and in normal controls.
    Dawber RP; Rundegren J
    J Eur Acad Dermatol Venereol; 2003 May; 17(3):271-5. PubMed ID: 12702063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RF - Bicalutamide: An Emergent Treatment Option in Trichology.
    Pegalajar-García MD; Gil-Villalba A; de la Torre-Gomar FJ
    Actas Dermosifiliogr; 2023 Oct; 114(9):812-815. PubMed ID: 37343820
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.